COVID‐19 and cardiovascular problems in elderly patients: Food for thought
Open Access
- 28 February 2021
- journal article
- review article
- Published by Wiley in Aging Medicine
- Vol. 4 (2), 146-152
- https://doi.org/10.1002/agm2.12149
Abstract
The global number of COVID‐19 infections, as of December 23, 2020, stood at approximately 79 million, with over 1.7 million deaths. The development of vascular inflammation may also contribute to a hypercoagulable state and endothelial dysfunction in such patients. It is known that multi‐organ damage is more likely in patients with sepsis if they develop coagulopathy and that inhibition of thrombin synthesis can have a positive impact in reducing mortality. In this review, we will focus on the protection of the most fragile groups of the population, such as the elderly. This segment of the population will be a key issue and probably of primary interest to all. Biomarkers appear to be extremely useful as an indicator of what is happening from a pathophysiological point of view in the heart, allowing us to better stratify the prognosis of our patients affected by COVID‐19, especially in the most severe cases and those with comorbidities.Keywords
This publication has 66 references indexed in Scilit:
- Intussusceptive Angiogenesis: A Biologically Relevant Form of AngiogenesisJournal of Vascular Research, 2012
- SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferonCurrent Opinion in Virology, 2012
- Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysisJournal of Hypertension, 2008
- Age- and gender-related difference of ACE2 expression in rat lungLife Sciences, 2006
- Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2The EMBO Journal, 2005
- Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic reviewBMJ, 2004
- Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesisThe Journal of Pathology, 2004
- Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trialsThe Lancet, 2003
- Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirusNature, 2003
- Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trialsThe Lancet, 2000